KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 86 filers reported holding KINNATE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $75,388 | +2.5% | 12,062 | 0.0% | 0.00% | – |
| Q4 2022 | $73,578 | -48.2% | 12,062 | +1.4% | 0.00% | – |
| Q3 2022 | $142,133 | -8.0% | 11,894 | -2.9% | 0.00% | – |
| Q2 2022 | $154,523 | +13.8% | 12,254 | +1.6% | 0.00% | – |
| Q1 2022 | $135,773 | -47.6% | 12,058 | -17.6% | 0.00% | – |
| Q4 2021 | $259,000 | -18.6% | 14,634 | +6.0% | 0.00% | – |
| Q3 2021 | $318,000 | +34.7% | 13,805 | +82.5% | 0.00% | – |
| Q1 2021 | $236,000 | – | 7,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 3,525,957 | $4,936,340 | 7.88% |
| Foresite Capital Management IV, LLC | 9,671,643 | $13,540,300 | 7.52% |
| Vida Ventures Advisors, LLC | 2,207,772 | $3,090,881 | 4.78% |
| Lynx1 Capital Management LP | 1,997,006 | $2,795,808 | 1.85% |
| Nextech Invest Ltd. | 2,329,480 | $3,261,272 | 0.99% |
| Orbimed Advisors | 8,009,729 | $11,213,621 | 0.24% |
| Novo Holdings A/S | 815,707 | $1,141,990 | 0.08% |
| DAFNA Capital Management LLC | 105,179 | $147,251 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 374,291 | $524 | 0.04% |
| Rock Springs Capital Management LP | 405,811 | $568,135 | 0.02% |